WSI Co., Ltd. Logo

WSI Co., Ltd.

Develops, manufactures, and distributes pharmaceuticals and medical devices.

299170 | KO

Overview

Corporate Details

ISIN(s):
KR7299170001
LEI:
Country:
South Korea
Address:
서울특별시 송파구 삼학사로 47(삼전동) -, 서울특별시

Description

WSI Co., Ltd. is a healthcare company engaged in the development, manufacturing, and distribution of pharmaceuticals and medical devices. Founded in 2016, the company focuses on providing safe and technologically advanced products to improve health and well-being. Its portfolio includes a range of medical devices, with a specialization in solutions for spinal joints, as well as pharmaceuticals such as local hemostatic agents and blood substitutes. WSI leverages its professional expertise and a commitment to research and development to deliver innovative and competitive medical solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-09-08 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 87.0 KB
2022-08-16 00:00
반기보고서 (2022.06)
Korean HTML 1.1 MB
2022-07-27 00:00
전환가액의조정(제2회차)
Korean HTML 11.2 KB
2022-05-16 00:00
분기보고서 (2022.03)
Korean HTML 1.2 MB
2022-04-19 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 125.0 KB
2022-03-30 00:00
정기주주총회결과
Korean HTML 24.6 KB
2022-03-22 00:00
감사보고서제출
Korean HTML 25.0 KB
2022-03-22 00:00
사업보고서 (2021.12)
Korean HTML 434.3 KB
2022-03-15 00:00
주주총회소집결의
Korean HTML 10.8 KB
2022-03-15 00:00
주주총회집중일개최사유신고
Korean HTML 4.9 KB
2022-03-15 00:00
주주총회소집공고
Korean HTML 204.5 KB
2022-02-17 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean HTML 12.2 KB
2022-02-03 00:00
주요사항보고서(유형자산양수결정)
Korean HTML 12.2 KB
2022-01-27 00:00
전환가액의조정(제2회차)
Korean HTML 10.7 KB
2022-01-04 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 59.7 KB

Automate Your Workflow. Get a real-time feed of all WSI Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WSI Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WSI Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.